Gene-Silencing Technique Targets Scarring
• http://www.technologyreview.com, Susan YoungA biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
A biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
